Home > National roadmap on State-level efforts to end the nation’s drug overdose epidemic leading-edge practices and next steps to remove barriers to evidence-based patient care .

American Medical Association, Manatt Health. (2020) National roadmap on State-level efforts to end the nation’s drug overdose epidemic leading-edge practices and next steps to remove barriers to evidence-based patient care . Chicago: AMA and Manatt Health.

[img]
Preview
PDF (National roadmap on State-level efforts to end the nation’s drug overdose epidemic)
8MB

The American Medical Association (AMA) and Manatt Health released a national policy roadmap in September 2019 to guide policymakers in taking action to help end the nation’s opioid epidemic. This expanded 2020 roadmap starts with our 2019 policy recommendations and an assessment of progress made.

The results are mixed, with the COVID-19 pandemic creating new challenges as well as the fact that the opioid epidemic has now become a much more complicated and deadly epidemic due to illicitly manufactured fentanyl, methamphetamine, cocaine and heroin. Overdose and death related to prescription opioids has decreased slightly but remains far too high.

In addition to providing a more robust evidence base with more than 200 citations and references that highlight both the complicated nature of the nation’s drug overdose epidemic and the work being done in the states to progressively combat it, the 2020 roadmap provides important emphasis on addressing racial inequities in care for historically marginalized and minoritized communities.

The 2020 roadmap also goes into far more detail than 2019 in providing actionable recommendations and tangible examples for state legislatures, departments of insurance, attorneys general, state Medicaid officials and other key policymakers.

The 2020 national roadmap lays out specific recommendations across six major policy areas:

  • Increase access to evidence-based treatments to help patients with a substance use disorder.
  • Enforce mental health and substance use disorder parity laws.
  • Ensure access to addiction medicine, psychiatry and other trained physicians.
  • Improve access to multidisciplinary, multimodal care for patients with pain.
  • Expand harm reduction efforts to reduce death and disease.
  • Improve monitoring and evaluation.

Repository Staff Only: item control page